Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28233367 | 0.87 | — | — | |
| Water SCHEMBL4114559 | 0.82 | — | — | |
| Water SCHEMBL29152753 | 0.82 | — | — | |
| Water SCHEMBL1759 | 0.82 | — | — | |
| Water SCHEMBL7430 | 0.82 | — | — | |
| Water SCHEMBL27455594 | 0.82 | — | — | |
| Water SCHEMBL28097199 | 0.82 | — | — | |
| Water SCHEMBL6142606 | 0.82 | — | — | |
| Water SCHEMBL8143527 | 0.82 | — | — | |
| Water SCHEMBL25436825 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117224799-A | Intelligent control method and early warning system of anesthesia respirator | 南京舒普思达医疗设备有限公司 | 2023-12-15 | — | — | CN | claimed |
| US-20260144837-A1 | GLP-1R AGONIST COMPOSITIONS AND METHODS OF USING | JDS THERAPEUTICS, LLC (US) | 2026-05-28 | — | — | US | disclosed |
| US-12622938-B2 | Compositions and methods for modulating inflammatory response | TURTLE BEAR HOLDINGS, LLC (US) | 2026-05-12 | — | — | US | disclosed |
| US-12622940-B2 | Combined fungal composition for modulating an inflammatory response | TURTLE BEAR HOLDINGS, LLC (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260124163-A1 | SOFT GUMMY | OYSTERSHELL NV (BE) | 2026-05-07 | — | — | US | disclosed |
| US-20260108544-A1 | TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH | TURTLE BEAR HOLDINGS LLC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260102416-A1 | COMPOSITION OF MATTER FOR TREATING AT A MEDICAL CONDITION AND METHODS OF USE AND MANUFACTURE THEREOF | TLCO HOLDINGS INC. (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260102338-A1 | SOFT GUMMY | OYSTERSHELL NV (BE) | 2026-04-16 | — | — | US | disclosed |
| US-20260091130-A1 | INJECTABLE FORMULATIONS OF PARP INHIBITORS AND USES THEREOF | ZYMERON CORP (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4709378-A1 | COMPOUNDS FOR NOS-RELATED CANCERS AND METHODS OF USE | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2026-03-18 | — | — | EP | disclosed |
| CN-114377262-A | Quantitative feeding device for anesthesia machine | 吉林大学 | 2022-04-22 | — | — | CN | disclosed |
| US-11292791-B2 | Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors | FORMA THERAPEUTICS, INC. (US) | 2022-04-05 | — | — | US | disclosed |
| US-11287187-B2 | Methods and systems for drying softgels with hydrophilic fills | BARLEAN'S ORGANIC OILS, LLC (US) | 2022-03-29 | — | — | US | disclosed |
| US-11279687-B2 | Compounds and compositions for the inhibition of NAMPT | VALO HEALTH, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| US-20220073452-A1 | ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS | VALO HEALTH, INC. | 2022-03-10 | — | — | US | disclosed |
| US-11267902-B2 | Crystalline antibody formulations | AMGEN INC. | 2022-03-08 | — | — | US | disclosed |
| WO-2022046960-A1 | COMPOSITION AND METHODS FOR TREATMENT OR PROPHYLAXIS OF CORONAVIRUS AND CANCERS | BETAHEALTH, LLC (US) | 2022-03-03 | — | — | WO | disclosed |
| US-20220062219-A1 | COMPOSITION AND METHOD FOR TREATING OR PROPHYLAXIS OF CORONAVIRUS AND CANCERS | BETAHEALTH, LLC | 2022-03-03 | — | — | US | disclosed |
| EP-3946212-A1 | METHODS AND SYSTEMS FOR DRYING SOFTGELS WITH HYDROPHILIC FILLS | Barlean's Organic Oils, LLC (US) | 2022-02-09 | — | — | EP | disclosed |
| US-4490294-A | Pure salts of clavulanic acid, e.g. lithium clavulanate | BEECHAM GROUP P.L.C. (GB) | 1984-12-25 | — | — | US | disclosed |